Delivery Order SPE2DB20D2014-SPE2DB24FC39A

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,643.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product used in medical treatment. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,109.20, is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 13, 2024. This award is not associated with a set-aside...
This federal contract award, valued at $7,699.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of July 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $2,196.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22FP9L2) for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $3,748.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a completion date of February 12, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $10,951.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a completion date of June 14, 2023. The award is a Delivery Order contract, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIGAMOX 0.5% eye drops. The delivery order, valued at $1,740.27, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $7,818.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide VIGAMOX 0.5% eye drops. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical and medical supplies for military healthcare programs. The contract does...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,218.40 fixed-price delivery order is for the supply of VIGAMOX 0.5% eye drops, a pharmaceutical product used for medical care. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $8,447.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with an ultimate completion date of October 9, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded several indefinite...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC39A
    Delivery Order

This federal contract award, valued at $6,020.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIGAMOX 0.5% eye drops, a pharmaceutical product, with a completion date of July 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this contract award.

Generated 5/17/25, 10:00 AM